Clinical Validation of New OCT System
Completed
- Conditions
- Subjects Presenting With Normal or With Ocular Pathology
- Registration Number
- NCT01809704
- Lead Sponsor
- Topcon Medical Systems, Inc.
- Brief Summary
To demonstrate clinical substantial equivalence of DRI OCT-1 as comparable to the commercially available Cirrus
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 87
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retinal Thickness Day 1
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
Hamilton Glaucoma Center
🇺🇸La Jolla, California, United States
Murray Fingeret
🇺🇸Jamaica, New York, United States
Vitreous Retina Macula Consultants of New York
🇺🇸New York, New York, United States
Hamilton Glaucoma Center🇺🇸La Jolla, California, United States